Pharmacological Stimulation of Mitochondrial Biogenesis Using the Food and Drug Administration-Approved ?2-Adrenoreceptor Agonist Formoterol for the Treatment of Spinal Cord Injury.

Pharmacological Stimulation of Mitochondrial Biogenesis Using the Food and Drug Administration-Approved ?2-Adrenoreceptor Agonist Formoterol for the Treatment of Spinal Cord Injury. J Neurotrauma. 2019 03 19; 36(6):962-972.

View in: PubMed

subject areas

Adrenergic beta-2 Receptor Agonists
Animals
Female
Formoterol Fumarate
Mice
Mice, Inbred C57BL
Mitochondria
Organelle Biogenesis
Recovery of Function
Spinal Cord Injuries

authors with profiles

Stephen Tomlinson